Live from the NIH registry
Studies recruiting near Palmdale right now
Top 25 of 119 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: SWOG Cancer Research Network
Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial
Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
N/A
Interventional 216 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: City of Hope Medical Center
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 2
Interventional 224 participants sought
Gastro Care Institute — Lancaster, California (7.4 mi)
· Sponsor: Genentech, Inc.
Efficacy of a Multi-level School Intervention for LGBTQ Youth
Depression, Anxiety
N/A
Interventional 228 participants sought
Crescenta Valley High School — La Crescenta-Montrose, California (26.1 mi)
· Sponsor: Washington University School of Medicine
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
Chronic Spontaneous Urticaria
Phase 2
Interventional 200 participants sought
Antelope Valley Clinical Trials — Lancaster, California (7.4 mi)
· Sponsor: Pfizer
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: National Cancer Institute (NCI)
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Sylmar, California (27.8 mi)
· Sponsor: AstraZeneca
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Lancaster, California (7.4 mi)
· Sponsor: Alnylam Pharmaceuticals
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
Urinary Tract Infections
Phase 2
Interventional 318 participants sought
Research Site 131 — Lancaster, California (7.4 mi)
· Sponsor: Locus Biosciences
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Diabetes Mellitus, Type 2, PreDiabetes
N/A
Interventional 7,500 participants sought
Chemidox Clinical Trials — Lancaster, California (7.4 mi)
· Sponsor: Cleerly, Inc.
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 19 — Palmdale, California (1.2 mi)
· Sponsor: BioStem Technologies
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 2
Interventional 82 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: City of Hope Medical Center
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
San Fernando — San Fernando, California (28.8 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Phase 3
Interventional 6,712 participants sought
Amicis Research Center - Valencia — Santa Clarita, California (28.6 mi)
· Sponsor: Boehringer Ingelheim
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis
Phase 3
Interventional 1,800 participants sought
Om Research, LLC — Lancaster, California (7.4 mi)
· Sponsor: Boehringer Ingelheim
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Om Research LLC — Lancaster, California (7.4 mi)
· Sponsor: Eli Lilly and Company
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 4
Interventional 350 participants sought
GSK Investigational Site — Tujunga, California (25.8 mi)
· Sponsor: GlaxoSmithKline
A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
Crohn's Disease
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400001 — Lancaster, California (7.4 mi)
· Sponsor: Sanofi
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Phase 2, Phase 3
Interventional 1,092 participants sought
Om Research, LLC 1 — Lancaster, California (7.4 mi)
· Sponsor: Janssen Research & Development, LLC
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus, T2DM
Phase 2
Interventional 180 participants sought
Care Access Research - Santa Clarita — Santa Clarita, California (28.6 mi)
· Sponsor: Hanmi Pharmaceutical Company Limited
Telehealth vs In-Person Evaluation of Addiction Treatment After Visiting the Emergency Department
Opioid Use Disorder
N/A
Interventional 528 participants sought
Olive View - UCLA Medical Center Emegency Department — Sylmar, California (27.8 mi)
· Sponsor: University of California, Davis
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small-Cell Lung
Phase 2
Interventional 480 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: Janssen Research & Development, LLC
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
USC Norris Santa Clarita Oncology — Santa Clarita, California (28.6 mi)
· Sponsor: NRG Oncology
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 3
Interventional 269 participants sought
City of Hope Antelope Valley — Lancaster, California (7.4 mi)
· Sponsor: NRG Oncology